DK2870141T3 - Methanthion-forbindelser med antivirus-aktivitet - Google Patents
Methanthion-forbindelser med antivirus-aktivitetInfo
- Publication number
- DK2870141T3 DK2870141T3 DK13722781.5T DK13722781T DK2870141T3 DK 2870141 T3 DK2870141 T3 DK 2870141T3 DK 13722781 T DK13722781 T DK 13722781T DK 2870141 T3 DK2870141 T3 DK 2870141T3
- Authority
- DK
- Denmark
- Prior art keywords
- methanthion
- compounds
- antivirus activity
- compound
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000002155 anti-virotic effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648700P | 2012-05-18 | 2012-05-18 | |
| US201261659516P | 2012-06-14 | 2012-06-14 | |
| US201261666286P | 2012-06-29 | 2012-06-29 | |
| US201361774991P | 2013-03-08 | 2013-03-08 | |
| PCT/EP2013/060266 WO2013171334A1 (en) | 2012-05-18 | 2013-05-17 | Methanethione compounds having antiviral activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2870141T3 true DK2870141T3 (da) | 2018-01-29 |
Family
ID=48444409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13722781.5T DK2870141T3 (da) | 2012-05-18 | 2013-05-17 | Methanthion-forbindelser med antivirus-aktivitet |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9359310B2 (enExample) |
| EP (1) | EP2870141B1 (enExample) |
| JP (2) | JP6484168B2 (enExample) |
| KR (1) | KR102092207B1 (enExample) |
| CN (1) | CN104540810B (enExample) |
| AU (1) | AU2013261735B2 (enExample) |
| BR (1) | BR112014028632B1 (enExample) |
| CA (1) | CA2879816C (enExample) |
| CL (1) | CL2014003116A1 (enExample) |
| DK (1) | DK2870141T3 (enExample) |
| EA (1) | EA029044B1 (enExample) |
| ES (1) | ES2657942T3 (enExample) |
| IL (1) | IL235742A0 (enExample) |
| IN (1) | IN2014DN10658A (enExample) |
| MX (1) | MX356846B (enExample) |
| MY (1) | MY169094A (enExample) |
| NZ (1) | NZ702073A (enExample) |
| SG (1) | SG11201407703QA (enExample) |
| WO (1) | WO2013171334A1 (enExample) |
| ZA (1) | ZA201409220B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6484168B2 (ja) * | 2012-05-18 | 2019-03-13 | ヴィロノヴァ・インフルエンザ・アクチェボラーグ | 抗ウイルス活性を有するメタンチオン化合物 |
| CN107056762B (zh) * | 2016-12-22 | 2020-08-28 | 四川百利药业有限责任公司 | 一种用作抗流感病毒的双羰基类似物 |
| WO2021204923A1 (en) | 2020-04-09 | 2021-10-14 | Vironova Medical Ab | Antiviral agents |
| WO2021204924A1 (en) | 2020-04-09 | 2021-10-14 | Vironova Medical Ab | Compounds for use in the treatment of hypercytokinemia |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642390B2 (en) | 2001-07-11 | 2003-11-04 | Lexicon Pharmaceuticals, Inc. | One step synthesis of 1,2,3-triazole carboxylic acids |
| AU2004218260A1 (en) * | 2003-01-28 | 2004-09-16 | Aventis Pharma S.A. | N-aryl heteroaromatic products, compositions containing same and use thereof |
| EP2278879B1 (en) | 2008-04-21 | 2016-06-15 | PATH Drug Solutions | Compounds, compositions and methods comprising oxadiazole derivatives |
| RU2012104214A (ru) | 2009-08-05 | 2013-09-10 | Верситек Лимитед | Противовирусные соединения и способы их получения и применения |
| BR112013007651A2 (pt) * | 2010-09-28 | 2019-09-24 | Bristol-Myers Squibb Company | análogos de piperazina com grupos heteroarila substituídos como antivirais de influenza de amplo espectro |
| EP2484655A1 (en) | 2011-02-04 | 2012-08-08 | Vironova AB | A thionation process and a thionating agent |
| JP6484168B2 (ja) * | 2012-05-18 | 2019-03-13 | ヴィロノヴァ・インフルエンザ・アクチェボラーグ | 抗ウイルス活性を有するメタンチオン化合物 |
| JP6762767B2 (ja) * | 2016-06-01 | 2020-09-30 | キヤノン株式会社 | 撮像素子、撮像装置、および撮像信号処理方法 |
-
2013
- 2013-05-17 JP JP2015512081A patent/JP6484168B2/ja not_active Expired - Fee Related
- 2013-05-17 EA EA201401277A patent/EA029044B1/ru not_active IP Right Cessation
- 2013-05-17 SG SG11201407703QA patent/SG11201407703QA/en unknown
- 2013-05-17 US US14/401,545 patent/US9359310B2/en not_active Expired - Fee Related
- 2013-05-17 CN CN201380038170.2A patent/CN104540810B/zh not_active Expired - Fee Related
- 2013-05-17 KR KR1020147035090A patent/KR102092207B1/ko not_active Expired - Fee Related
- 2013-05-17 AU AU2013261735A patent/AU2013261735B2/en not_active Ceased
- 2013-05-17 CA CA2879816A patent/CA2879816C/en active Active
- 2013-05-17 IN IN10658DEN2014 patent/IN2014DN10658A/en unknown
- 2013-05-17 MX MX2014014007A patent/MX356846B/es active IP Right Grant
- 2013-05-17 EP EP13722781.5A patent/EP2870141B1/en active Active
- 2013-05-17 BR BR112014028632A patent/BR112014028632B1/pt not_active IP Right Cessation
- 2013-05-17 DK DK13722781.5T patent/DK2870141T3/da active
- 2013-05-17 MY MYPI2014003200A patent/MY169094A/en unknown
- 2013-05-17 WO PCT/EP2013/060266 patent/WO2013171334A1/en not_active Ceased
- 2013-05-17 NZ NZ702073A patent/NZ702073A/en not_active IP Right Cessation
- 2013-05-17 ES ES13722781.5T patent/ES2657942T3/es active Active
-
2014
- 2014-11-17 CL CL2014003116A patent/CL2014003116A1/es unknown
- 2014-11-17 IL IL235742A patent/IL235742A0/en active IP Right Grant
- 2014-12-15 ZA ZA2014/09220A patent/ZA201409220B/en unknown
-
2017
- 2017-11-09 JP JP2017216649A patent/JP2018065817A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US9359310B2 (en) | 2016-06-07 |
| WO2013171334A1 (en) | 2013-11-21 |
| JP6484168B2 (ja) | 2019-03-13 |
| BR112014028632A2 (pt) | 2017-06-27 |
| KR102092207B1 (ko) | 2020-03-23 |
| CL2014003116A1 (es) | 2015-08-07 |
| KR20150012289A (ko) | 2015-02-03 |
| US20150133468A1 (en) | 2015-05-14 |
| EP2870141A1 (en) | 2015-05-13 |
| EP2870141B1 (en) | 2017-11-22 |
| MX356846B (es) | 2018-06-18 |
| IL235742A0 (en) | 2015-02-01 |
| JP2015517516A (ja) | 2015-06-22 |
| SG11201407703QA (en) | 2015-01-29 |
| MY169094A (en) | 2019-02-18 |
| ES2657942T3 (es) | 2018-03-07 |
| CN104540810A (zh) | 2015-04-22 |
| MX2014014007A (es) | 2015-05-11 |
| NZ702073A (en) | 2017-07-28 |
| BR112014028632B1 (pt) | 2020-01-28 |
| CA2879816C (en) | 2020-07-07 |
| JP2018065817A (ja) | 2018-04-26 |
| EA201401277A1 (ru) | 2015-04-30 |
| ZA201409220B (en) | 2016-08-31 |
| AU2013261735A1 (en) | 2015-01-22 |
| HK1210165A1 (en) | 2016-04-15 |
| EA029044B1 (ru) | 2018-02-28 |
| BR112014028632A8 (pt) | 2018-04-03 |
| IN2014DN10658A (enExample) | 2015-08-28 |
| CA2879816A1 (en) | 2013-11-21 |
| AU2013261735B2 (en) | 2017-07-20 |
| CN104540810B (zh) | 2017-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201390885A1 (ru) | Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса | |
| NZ703040A (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| LT3456721T (lt) | Junginių, pasižyminčių živ integrazės inhibavimo aktyvumu, gavimo būdas | |
| PH12014502739A1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| UA114087C2 (xx) | Похідні піридину | |
| LT2755473T (lt) | Paraziticidinės kompozicijos, apimančios izoksazolino veiklųjį agentą, būdai ir jų panaudojimai | |
| LT2916860T (lt) | Diabeto gydymui skirta kompozicija, apimanti oksintomodulino analogą | |
| UA116395C2 (uk) | ПОХІДНІ ТРИАЗОЛ[4,5-b]ПІРИМІДИНУ | |
| EA201591064A1 (ru) | Новые производные пиридина | |
| NZ703066A (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| PH12017500048A1 (en) | Pyridone derivative having tetrahydropyranylmethyl group | |
| JO3063B1 (ar) | مركب مبتكر وطرق لانتاجه | |
| CA2873723A1 (en) | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase | |
| EA201490643A1 (ru) | Новые производные бетулиновой кислоты с противовирусной активностью | |
| WO2014152716A8 (en) | Substituted heterocyclic compounds for treating or preventing viral infections | |
| PH12015502118A1 (en) | Pyridin-4-yl derivatives | |
| PH12014502743A1 (en) | Carbamate/urea derivatives | |
| UA111333C2 (uk) | Спосіб одержання l-аргінінової солі периндроприлу | |
| BR112013005609A2 (pt) | composto de fórmula (i), composição, uso de um composto e novos compostos, processos, método e usos | |
| HK1221645A1 (zh) | Vmat2的苯并喹啉抑制剂 | |
| EP2725024A4 (en) | HETEROCYCLIC AZOL COMPOUND, METHOD OF MANUFACTURING THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| WO2014116772A3 (en) | Squaric derivatives for the treatment of hepatitis c | |
| EA201401277A1 (ru) | Соединения метантиона, обладающие противовирусной активностью | |
| DOP2015000007A (es) | Métodos para preparar triazolopiridinas sutituidas | |
| MX2013007726A (es) | Derivados de 2-metoxi-piridin-4-ilo. |